CBD

CBD, United States

FDA Launches Biggest Cannabis Data Collection Plan Yet

The Food and Drug Administration has been on a march to collect cannabinoid-related data. The “Cannabis-Derived Products Data Acceleration Plan” released this month is its most robust effort.

CBD, Hemp

FDA Rejects Two Applications for CBD-based Dietary Supplements

Epidiolex strikes again: the FDA-approved CBD-based pharmaceutical is complicating other uses of CBD.

CBD

Cannabis and Clinical Trials: How the First Cannabis Extract Got FDA Approval

CSU Pueblo hosted a pharmacist at Greenwich Biosciences to talk about the company’s path with Epidiolex, a CBD-based medicine extracted from cannabis plants.

CBD

Consumer Brands Association Pushes Lawmakers on CBD Amid FDA Inaction

The group, which includes Coca-Cola and Kellogg’s as members, says its membership is “CBD curious” but that the lack of federal regulation is keeping major brands at bay.

CBD

Hemp in Animal Food: Is a Path Taking Shape?

“I’m getting very hopeful that we're headed down the road to seeing some hemp-derived ingredients approved for use in animal food,” said the FDA’s Deputy Director in the Division of Animal Feeds.

CBD

Amid Pressure to Publish CBD Rules, FDA Reiterates Need for “Better Data”

The FDA, which has been crafting rules for CBD products since 2019, says it is seeking partnerships, from academia to government and the cannabis industry, to “develop the foundation for more robust CBD data collection.”

CBD

FDA, DOJ Officials Talk Cannabis and CBD at Food and Drug Conference

The Food and Drug Law Institute is hosting officials from several federal agencies this week to discuss cannabis policies.

CBD

GW Pharmaceuticals and GNC met with White House on CBD

One company is focused on the future of CBD in supplements. The other, on its future in pharmaceuticals.

CBD, Research

The FDA Wants to Help Cannabis Businesses Advance Research

During a recent webinar, the FDA detailed how its Drug Master Files process could speed up research, while keeping proprietary information secret.

CBD

Here’s What Else We Know About the White House Meetings on CBD

Among the new names on the list of entities seeking to discuss the FDA’s forthcoming rules on CBD products: American Bankers Association and Columbia Care.

CBD

FDA Approves Epidiolex for New Condition That Causes Benign Tumors, Seizures

Epidiolex contains cannabidiol, or CBD, extracted from cannabis plants, and was first approved to treat severe forms of epilepsy.

CBD

Hemp Groups to Meet with White House on FDA CBD Policy

The Food and Drug Administration drafted its long-awaited CBD policy, and sent it to the White House Office of Management and Budget for approval, a final step before publication.

CBD

Federal DOT Discusses Hemp Legalization’s Impact on Commercial Drivers

The US Department of Transportation committee heard a presentation and asked questions about how the passage of the 2018 Farm Bill, and proliferation of CBD, is affecting the nation’s commercial drivers.

CBD

From Law Enforcement to Retail, a New Coalition Forms to Focus on CBD Regulation

Consumer Brands Association, which counts among its members Kellogg’s, Coca-Cola Company, and PepsiCo, Inc., brought together a diverse group to focus on federal CBD policies.

CBD

Charlotte Figi, Who Inspired the Movement for CBD as Medicine, Dies

Figi’s story raised awareness about the potential for CBD to reduce seizures, and led to CBD legislation and research around the world.

CBD

In a First, a Cannabis-Derived Pharma Product Is Descheduled in the US

The DEA has taken Epidiolex, a CBD-based formula for rare forms of epilepsy, completely off its list of controlled substances. Why? The 2018 Farm Bill.